Israeli team says AI platform can predict which drugs are safe

Robert Langer, the co-founder of Moderna and a lauded MIT professor, said, "We are at the tipping point of the modernization of drug discovery" and that the "Quris platform could be a significant value to pharma companies and the health of society at large." Langer is a member of the scientific advisory board of Quris, which officially launched this week and announced $9 million in seed funding to support its efforts. Nobel laureate Aaron Ciechanover is the chairman of the company's scientific advisory board. Quris, based in Israel and Boston, is an artificial intelligence (AI) company operating in the pharmaceutical space. Its team has developed an AI platform to predict which drug candidates will work most safely and effectively in humans.